Organisation
Medical Oncology
Current researchers
1 - 10 of 21 results
- Sandrine Aspeslagh (Member)
- Gil Awada (Member)
- Amy De Haar-Holleman (Member)
- Kurt De Neef (Member)
- Lore Decoster (Member)
- Iris Dirven (Member)
- Christel Fontaine (Member)
- Xenia Geeraerts (Member)
- Mathijs Christiaan Goossens (Member)
- Sofie Joris (Member)
Projects
1 - 2 of 2
- Health-related quality of life, psychosocial outcome and neurocognitive function in metastatic cancer survivors treated with immunotherapy, followed by integrative neurocognitive remediation therapyFrom1 Nov 2022 → TodayFunding: FWO fellowships
- A randomized phase II clinical trial in NSCLC combining SBRT and I.V. anti-PD-1 with or without I.T. anti-CTLA-4/anti-PD-L1 plus CD1c+ myDCFrom1 Oct 2019 → TodayFunding: FWO Applied Biomedical Research (TBM)
Publications
1 - 10 of 310
- Bacterial CD1d-restricted glycolipids induce IL-10 production by human regulatory T cells upon cross-talk with invariant NKT cells(2013)
Authors: Koen Venken, Tine Decruy, Sandrine Aspeslagh, Serge Van Calenbergh, Bart N Lambrecht, Dirk Elewaut
Pages: 2174-2183 - Phase I dose-escalation study of plitidepsin in combination with bevacizumab in patients with refractory solid tumors(2016)
Authors: Sandrine Aspeslagh, Ahmad Awada, Arturo S Matos-Pita, Philippe Aftimos, Ratislav Bahleda, Andréa Varga, Jean-Charles Soria
Pages: 1021-1027 - Incidence, evolution and risk factors of hypophosphatemia in patients with solid tumors receiving ferric carboxymaltose(2022)
Authors: Alexander Decruyenaere, Koen Kortbeek, Sigurd Delanghe, Sylvie Rottey, Hannelore Denys, Lore Lapeire
Pages: 1-10 - Impact of solid cancer on in-hospital mortality overall and among different subgroups of patients with COVID-19(2020)
Authors: Evandro de Azambuja, Mariana Brandão, Hans Wildiers, Annouschka Laenen, Sandrine Aspeslagh, Christel Fontaine, Joelle Collignon, Willem Lybaert, Jolanda Verheezen, Annemie Rutten, et al.
- Immune checkpoint blockade for organ transplant patients with advanced cancer(2019)
Authors: Pauline De Bruyn, Dirk Van Gestel, Piet Ost, Vibeke Kruse, Lieve Brochez, Hans Van Vlierberghe, Arnaud Devresse, Véronique Del Marmol, Alain Le Moine, Sandrine Aspeslagh
Pages: 54-64 - Epigenetic modifiers as new immunomodulatory therapies in solid tumours(2018)
Authors: S Aspeslagh, D Morel, Jean-Charles Soria, Sophie Postel-Vinay
Pages: 812-824 - Supportive care for cancer patients(2021)
Authors: Christel Fontaine, Marie-Aline Echterbille, Jean Klastersky
Pages: 5507-5512 - Safety and efficacy of anti-programmed death 1 antibodies in patients with cancer and pre-existing autoimmune or inflammatory disease(2018)
Authors: François-Xavier Danlos, Anne-Laure Voisin, Valérie Dyevre, Jean-Marie Michot, Emilie Routier, Laurent Taillade, Stéphane Champiat, Sandrine Aspeslagh, Julien Haroche, Laurence Albiges, et al.
Pages: 21-29 - Insulin-like growth factor-1 (IGF-1) pathway targeting in the treatment in cancer(2011)
Authors: Lore Decoster, Eline Menu, Karin Vanderkerken, Jacques De Grève
Pages: 108-115 - The Controversial Role of PD-1 and Its Ligands in Gynecological Malignancies(2019)
Authors: Oliviero Marinelli, Daniela Annibali, Cristina Aguzzi, Sandra Tuyaerts, Frederic Amant, Maria Beatrice Morelli, Giorgio Santoni, Consuelo Amantini, Federica Maggi, Massimo Nabissi